secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0001664710-25-000055
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Keros CEO to speak at Goldman Sachs Healthcare Conference on June 9
-------------------------------------------------------------------

- CEO Jasbir Seehra to participate in a fireside chat at Goldman Sachs 46th Annual Global Healthcare Conference.
- Presentation scheduled for June 9, 2025 at 9:20 a.m. Eastern time.
- Live audio webcast available; archived replay on Keros website for up to 90 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471025000055/0001664710-25-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471025000055/kros-20250606.htm
  HTML page:      https://secwatch.observer/filing/0001664710-25-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer